Search

Home > New FDA Approvals > 132 – MALDI-TOF test for C. auris; FDA issues guidances for opioid use disorder; 510(k) clearance for beacon transponder used in lung SBRT
Podcast: New FDA Approvals
Episode:

132 – MALDI-TOF test for C. auris; FDA issues guidances for opioid use disorder; 510(k) clearance for beacon transponder used in lung SBRT
Category: Science & Medicine
Duration: 00:10:05
Publish Date: 2018-04-24 06:00:00
Description:

April 24, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:10 FDA authorizes new use of test, first to identify the emerging pathogen Candida auris https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605336.htm 

3:49 FDA encourages more widespread innovation and development of new treatments for opioid use disorder https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605235.htm https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605248.htm 

7:25 Varian Calypso anchored beacon transponder for lung receives FDA 510k clearance https://www.prnewswire.com/news-releases/varian-calypso-anchored-beacon-transponder-for-lung-receives-fda-510k-clearance-300633354.html

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0